AMYTH LTD
Company number 16122931 · Active · London WC2H 9JQ
AMYTH LTD is an active private limited company (company number 16122931) incorporated on 9 December 2024, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 31 December 2025, showing net assets of £2.
By net assets it sits in the lower half of 603 comparable companies in London (median £440, upper quartile £92k).
Key dates
- Incorporated
- 9 December 2024
- Next accounts due
- 30 September 2027 — in 343 days
- Confirmation statement due
- 23 December 2026 — in 62 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- Micro (Companies Act thresholds)
Financials — 1 period on record, latest ending 31 December 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £2 | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 60/100 (grade C)
- +10 Positive net assets — Net assets £2 at 2025-12-31
- 0 Newly incorporated — Incorporated 2024-12-09; no accounts due yet
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Mr George Pavlou — owns 25–50% of shares; holds 25–50% of voting rights · since 9 December 2024
- Mr Alexander George Pavlou — owns 25–50% of shares; holds 25–50% of voting rights · since 9 December 2024
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in London
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- MEIRAGTX GENE REGULATION LIMITED — London, inc. Dec 2024
- IB DEMETER II LTD — London, inc. Dec 2024
- MEIRAGTX MANUFACTURING LIMITED — London, inc. Dec 2024
- GENEXELLE LTD — London, inc. Dec 2024
- MASS BALANCE LTD — London, inc. Dec 2024
- NUCLEARMEDIX LIMITED — London, inc. Dec 2024
Reminders for AMYTH LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.